Research
Hormonal
Progressive resistance training is an effective nonpharmacologic intervention that slightly reduces resting systolic and diastolic blood pressure in hypertensive and nonhypertensive individuals.
If you have high blood pressure, adding progressive resistance training to your routine can help lower your resting blood pressure. This reduction, while small, shifts your blood pressure from the high-normal category to the normal category, reducing your risk of stroke and heart disease.
GoodSupportsHIGH confidence
Increasing scientific evidence now indicates that progressive resistance training is an effective nonpharmacologic intervention that may slightly reduce resting systolic and diastolic blood pressure.
Why this rating
Cites meta-analyses and guidelines from the Joint National Committee, indicating strong consensus.
Source
Resistance Training for Health and Performance
William J. Kraemer et al. · Current Sports Medicine Reports · 2002
DOI 10.1249/00149619-200206000-00007
narrative_reviewCited 338×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Progressive resistance training significantly increases muscle strength in elderly individuals, reversing age-related strength declines and improving functional ability.Strong
- Resistance training reduces body fat and increases basal metabolic rate, with high-volume workouts using large muscle masses and short rest periods being most conducive to fat loss.Good
- Resistance training improves glucose tolerance and insulin sensitivity, and modifying body composition through resistance training can delay the onset of insulin resistance.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →